Antiemetic Prophylaxis for Postdischarge Nausea and Vomiting After Hip Arthroscopy

Completed · Phase 4 · Has a placebo group

Conditions studied: Nausea and Vomiting, Postoperative

In brief

The study is a randomized placebo controlled trial to determine whether repeated postoperative prophylactic ondansetron ("Zofran") administration will prevent postoperative and/or postdischarge nausea and vomiting in patients undergoing ambulatory hip arthroscopy. Ondansetron will be administered in the intra- and post-operative period. These individuals will be followed on postoperative days 1, 2, and 3. It is hypothesized that the incidence of postdischarge nausea and vomiting (PDNV) will be significantly decreased by postoperative prophylactic administration of multiple doses of ondansetron (Zofran).

Key facts

Study ID
NCT00878228
Run by
Hospital for Special Surgery, New York
People needed
98
Starts
2009-04-01
Expected to finish
2010-02-01
Last updated by the study team
2013-01-31

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.